BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 37072485)

  • 1. Tumor resident memory CD8 T cells and concomitant tumor immunity develop independently of CD4 help.
    Medler TR; Kramer G; Bambina S; Gunderson AJ; Alice A; Blair T; Zebertavage L; Duhen T; Duhen R; Young K; Crittenden MR; Gough MJ
    Sci Rep; 2023 Apr; 13(1):6277. PubMed ID: 37072485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Heterogeneity of CD4
    Oja AE; Piet B; van der Zwan D; Blaauwgeers H; Mensink M; de Kivit S; Borst J; Nolte MA; van Lier RAW; Stark R; Hombrink P
    Front Immunol; 2018; 9():2654. PubMed ID: 30505306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Emerging Role of CD8
    Corgnac S; Boutet M; Kfoury M; Naltet C; Mami-Chouaib F
    Front Immunol; 2018; 9():1904. PubMed ID: 30158938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD103
    Corgnac S; Malenica I; Mezquita L; Auclin E; Voilin E; Kacher J; Halse H; Grynszpan L; Signolle N; Dayris T; Leclerc M; Droin N; de Montpréville V; Mercier O; Validire P; Scoazec JY; Massard C; Chouaib S; Planchard D; Adam J; Besse B; Mami-Chouaib F
    Cell Rep Med; 2020 Oct; 1(7):100127. PubMed ID: 33205076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD8+CD103+ tissue-resident memory T cells convey reduced protective immunity in cutaneous squamous cell carcinoma.
    Lai C; Coltart G; Shapanis A; Healy C; Alabdulkareem A; Selvendran S; Theaker J; Sommerlad M; Rose-Zerilli M; Al-Shamkhani A; Healy E
    J Immunother Cancer; 2021 Jan; 9(1):. PubMed ID: 33479027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intratumoral interleukin-2/agonist CD40 antibody drives CD4+ -independent resolution of treated-tumors and CD4+ -dependent systemic and memory responses.
    Jackaman C; Nelson DJ
    Cancer Immunol Immunother; 2012 Apr; 61(4):549-60. PubMed ID: 22002241
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resident memory T cells, critical components in tumor immunology.
    Mami-Chouaib F; Blanc C; Corgnac S; Hans S; Malenica I; Granier C; Tihy I; Tartour E
    J Immunother Cancer; 2018 Sep; 6(1):87. PubMed ID: 30180905
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TGF-β: Many Paths to CD103
    Qiu Z; Chu TH; Sheridan BS
    Cells; 2021 Apr; 10(5):. PubMed ID: 33922441
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating memory CD8
    Behr FM; Beumer-Chuwonpad A; Kragten NAM; Wesselink TH; Stark R; van Gisbergen KPJM
    Eur J Immunol; 2021 Jan; 51(1):151-166. PubMed ID: 32762051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cancer stem-like cells evade CD8
    Corgnac S; Damei I; Gros G; Caidi A; Terry S; Chouaib S; Deloger M; Mami-Chouaib F
    J Immunother Cancer; 2022 Apr; 10(4):. PubMed ID: 35418483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMDCs induce the generation of the CD103
    Huang Y; Zhou L; Zhang H; Zhang L; Xi X; Sun Y
    Cell Immunol; 2022 Apr; 374():104502. PubMed ID: 35306373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential requirements of CD4(+) T-cell signals for effector cytotoxic T-lymphocyte (CTL) priming and functional memory CTL development at higher CD8(+) T-cell precursor frequency.
    Umeshappa CS; Nanjundappa RH; Xie Y; Freywald A; Xu Q; Xiang J
    Immunology; 2013 Apr; 138(4):298-306. PubMed ID: 23113741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct recirculation potential of CD69
    Park SL; Mackay LK; Gebhardt T
    Immunol Cell Biol; 2016 Nov; 94(10):975-980. PubMed ID: 27328704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution, phenotype, functional and clinical relevance of CD8
    Shen Y; Li XL; Li YX; Shan ZG; Zhao YL; Cheng P; Zhao Z; Zhang JY; Chen W; Zhuang Y; Ma DY; Zou QM; Qiu Y; Peng LS
    Cancer Immunol Immunother; 2022 Jul; 71(7):1645-1654. PubMed ID: 34767045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implication of CD69
    Kim HD; Jeong S; Park S; Lee YJ; Ju YS; Kim D; Song GW; Lee JH; Kim SY; Shin J; Shin EC; Hwang S; Yoo C; Park SH
    Liver Int; 2021 Apr; 41(4):764-776. PubMed ID: 33548061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting resident memory T cell immunity culminates in pulmonary and systemic protection against Brucella infection.
    Wang H; Hoffman C; Yang X; Clapp B; Pascual DW
    PLoS Pathog; 2020 Jan; 16(1):e1008176. PubMed ID: 31951645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopamine Signaling Promotes Tissue-Resident Memory Differentiation of CD8+ T Cells and Antitumor Immunity.
    Chen Y; Yan SM; Pu Z; Feng J; Tan L; Li Y; Hu H; Huang W; Lin Y; Peng Z; He X; Huang F; Zhang H; Zhang Y
    Cancer Res; 2022 Sep; 82(17):3130-3142. PubMed ID: 35802647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-Resident Memory-Like CD8
    Yu S; Lao S; Yang B; Wu C
    J Immunol Res; 2021; 2021():6643808. PubMed ID: 33977110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue Resident CD8 Memory T Cell Responses in Cancer and Autoimmunity.
    Molodtsov A; Turk MJ
    Front Immunol; 2018; 9():2810. PubMed ID: 30555481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic Differences of CD103+ Tissue-Resident Memory T Cells Associated with Various Cancers.
    Park HS; Jeon Y; Lee H; Lee H; Kim YA; Park IA; Bang WS; Lee M; Cho YJ; Kim J; Gong G; Lee HJ
    Pathobiology; 2022; 89(2):116-126. PubMed ID: 34592745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.